Dr. Frances Shepherd CV - (NCRI) is

1. Kassam F, Shepherd FA, Johnston M, Visbal A, Feld R, Darling G, Keshavjee S, Pierre
A, Waddell T, Leighl NB. Referral Patterns for Adjuvant Chemotherapy in Patients with
Completely Resected Non-Small Cell Lung Cancer. Journal of Thoracic Oncol 2 (1): 39-
43, 2007.
2. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH,
Shulman L, Shepherd FA, Deschamps C, Livingston RB, Gandara D. Journal of Clin
Oncol 25 (3): 313-318, 2007.
3. Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, Ayoub J, Lago S,
deAlbuquerque Ribeiro R, Gerogianni A, Cyjon A, Noble J, Laberge F, Chan RT, Fenton
D, von Pawel J, Reck M, Shepherd FA. Symptom Improvement in Lung Cancer Patients
Treated with Erlotinib: Quality of life Analysis of the National Cancer Institute of
Canada Clinical Trials Group Study BR.21. J Clin Oncol 24(24: 3831-3837, 2007
4. Blackhall FH, Shepherd FA. Small Cell Lung Cancer and Targeted Therapies. Curr Opin
Oncol. 19 (2): 103-108, 2007
5. Seve P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dannagh L, Aviel-
Ronen S, Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T. Class III Beta-
Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in
Operable Non-Small Cell lung Cancer: Analysis of NCIC CTG JBR.10. Clin Cance Res
13 (3): 994-999, 2007.
6. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer
Incidence Among Canadian Kidney Transplant Recipients. Am J Transplant 2007; (4):
941-8.
7. Clark GM, Zabrowski DM, Culberston JL, Whitehead M, Savoie M, Seymour L,
Shepherd FA. Clinical Utility of Epidermal Growth Factor Receptor Expression for
Selecting Patients with Advanced Non-Small Cell Lung Cancer for Treatment with
Erlotinib. J Thorac Oncol. 2006 Oct 1 (8): 837-846.
8. Cheng S, Evans WK, Stys-Norman D, Shepherd FA; the Lung Cancer Disease Site
Group of Cancer Care Ontario’s Program in Evidence-Based Care. Chemotherapy for
Relapsed Small Cell Lung Cancer: A Systematic Revue and Practice Guideline. J Thorac
Oncol. 2007 Apr: 2 (4): 348-354.
9. Benamore R, Shepherd FA, Leighl N, Pintilie M, Patel M, Feld R, Herman S. Does
Intensive Follow-Up Alter Outcome in Patients with Advanced Lung Cancer? J Thorac
Oncol. 2007 Apr: 2 (4): 273-281.
10. Pepe C, Hasan B, Winton TL, Seymour L, Graham B, Livingston RB, Johnson DH,
Rigas JR, Ding K, Shepherd FA. Adjuvant Vinorelbine and Cisplatin in Elderly Patients:
National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 2007 Apr
20; 25 (12) 1553 – 1561.
11. Shepherd FA, Rosell R. Weighing Tumour biology in Treatment Decisions for Patients
with Non-Small Cell Lung Cancer. Supp J Thor Oncol 2007 Jun: 2 (6): S68 – S76
12. Rodin G, Walsh A, Zimmermann C, Gagliese L, Jonnes J, Shepherd FA, Moore M,
Braun M, Donner A, Mikulincer M. The contribution of attachment security and social
support to depressive symptoms in patients with metastatic cancer. Psychooncology.
2007; 12: 1080-91.
13. Rodin G, Zimmerman C, Rydall A, Jones J, Shepherd FA, Moore M, Fruh M, Donner
A, Gagliese L. The desire for Hastened Death in Patients with Metastatic Cancer. J Pain
Symptom Manage. 2007 Jun; 33 (6): 661-675.
14. Ng R, Hasan B, Mittman N, Florescu M, Shepherd FA, Ding K, Butts CA, Cormier Y,
Darling G, Goss GD, Inculet R, Seymour L, Winton T, Evans WK, Leighl NB; Working
Group on Economic Analysis; Lung Disease Site Group; National Cancer Institute of
Canada Clinical Trials Group. Economic Analysis of NCIC CTG JBR.10: a randomized
6